Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 8, 2023, and Announces Participation in Upcoming Investor Conference
25 Julho 2023 - 8:00AM
Business Wire
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and
orthopedics company, today announced that it will release its
second quarter 2023 financial results on Tuesday, August 8, 2023
after market close. The Company will host a conference call and
webcast to review results at 4:30 p.m. ET the same day.
Interested parties may access the conference call by dialing
(888) 330-2508 in the U.S., and (240) 789-2735 in all other
locations, and referencing the event passcode 9556380. A replay of
the call will be available for three weeks by dialing (800)
770-2030 in the U.S., and (647) 362-9199 in all other locations,
and entering the event passcode 9556380. A webcast of the
conference call and a copy of the release may be accessed at
ir.Orthofix.com.
Additionally, the Company today announced that it will
participate at the upcoming Canaccord Genuity 43rd Annual Growth
Conference in Boston, MA. Management is scheduled to present on
Thursday, August 10, 2023, at 10:30 a.m. ET. Interested parties can
access a live webcast of the presentation on the Investors section
of the Orthofix website at ir.Orthofix.com. An archived recording
of the event will be available for 90 days.
About Orthofix:
On January 5, 2023, Orthofix and SeaSpine merged to form a
leading global spine and orthopedics company with a comprehensive
portfolio of biologics, innovative spinal hardware, bone growth
therapies, specialized orthopedic solutions, and a leading surgical
navigation system. Its products are distributed in approximately 68
countries worldwide
The Company is headquartered in Lewisville, Texas and has
primary offices in Carlsbad, CA, with a focus on spine and
biologics product innovation and surgeon education, and Verona,
Italy, with an emphasis on product innovation, production, and
medical education for orthopedics. The combined Company’s global
R&D, commercial and manufacturing footprint also includes
facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale,
CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany,
Paris, France and Sao Paulo, Brazil. A new name for the combined
entity will be announced at a future date; the Company will
continue to operate as Orthofix until said announcement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230725826475/en/
Investor Relations Louisa Smith, Gilmartin Group
ir@orthofix.com
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024